Esophageal Carcinoma
75
22
30
24
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
11 trials with published results (15%)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
2.7%
2 terminated out of 75 trials
92.3%
+5.8% vs benchmark
15%
11 trials in Phase 3/4
46%
11 of 24 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 24 completed trials
Clinical Trials (75)
Timing of Minimally Invasive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
The Vanguard Study: Testing a New Way to Screen for Cancer
National Cancer Institute "Cancer Moonshot Biobank"
Effect of Feeding Jejunostomy on Sarcopenia in Patients With Esophageal Cancer
CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC
Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
18F-FSPG PET/CT as a Non-Invasive Imaging Biomarker for Treatment Response to Chemoradiation in Esophageal Cancer
Inter-Observer Delineation Differences in Esophageal Cancer GTV on MR, CT, and PET/CT Protokol šečerov Ermenc 28dec19
PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial
Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer
Yoga Program for Improving the Quality of Life in Couples Coping With Cancer
Impact of Prehabilitation in Oncology Via Exercise- Esophageal (IMPROVE-Esophageal)
TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
Impact of Arterial Partial Pressure of Oxygen on Anastomotic Leakage After Esophagectomy
PET-imaging of Two Vartumabs in Patients With Solid Tumors
Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program